OWL is a biotechnology company that uses metabolomics to develop early diagnosis products for highly prevalent diseases. The first disease targeted was fatty liver disease (non-alcoholic fatty liver disease and non-alcoholic fatty liver disease).
OWL has developed a simple, non-invasive diagnostic system based on a blood test. Until now, the only diagnostic procedure for this condition was a liver biopsy.
